New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 18, 2024 - Celltrion announced the FDA approval of Steqeyma (ustekinumab-stba), the 7th biosimilar to Janssen’s Stelara® (ustekinumab).
Download PDF
Return to publications
